Trending
- Anthracycline and antimetabolite, trigger distinct resistance mechanisms in TP53mut AML
- Subcutaneous Amivantamab Cuts Infusion Time in NSCLC Care
- Dual Biomarkers and Treatment Sequencing in HR+/HER2− mBC
- KST-6051 Receives FDA Fast Track Designation in KRAS-Mutant Solid Tumors
- FDA Approves Taletrectinib in TKI-Naive Advanced ROS1+ NSCLC
- Cancer patient told she will get drug which could make her life longer
- YAP1 induces hepatocellular carcinoma via DNA demethylation rather than by canonical driver gene mutations
- A Sellas immunotherapy study, long delayed, will end in failure
Thursday, September 17